Orazamide Tablets
| category | Olamira tablets | Other hangover products |
| Product nature | Rescue liver protection products, with rescue effect, no side effects | Mostly health care products or food, no real hangover function |
| Product Features | Hangover liver effect is good, the effective proportion of more than 95% hangover | Most people hang the wine in general |
| Production Process | Exclusive patent protection varieties | The process is simple and rough |
| Working time | Half an hour hangover effect | 12-48 hours, hangover slow effect |
| Branding | Loyalty to consumers | Repeat fewer buyers |
Wegmann et al. Reported that treatment with AICA deicacity (1) in rats with acute and chronic hepatitis due to ethanol resulted in partial recovery of respiration and glycogen levels, which stimulated the metabolism of nitrogen, phosphorus, hexahydrate and significant Detoxification effect, no effect on fat metabolism.
Anti-ethionine action
Katsuki et al. Reported that AICA (1) treatment of various liver damage rats found that their liver enzyme metabolism and tissue cells were found to be considerably improved.
Due to ethanol ethanethionine (ethanoletnionine) caused by fatty liver can be inhibited, due to low protein feed caused by liver ribonucleic acid reduction, and decreased activity of serum cholinesterase, etc., can also be inhibited.
Improve liver function
Wong iney Hong et al. Reported that glycosyl lactone, lipoic acid and AICA are effective drugs for improving liver function, but must be in the metabolic system, a sufficient amount of oxygen and sediment supply, in order to work, these substances as stimulants To act with.
Orazamide Tablets instructions [Drug Name] Common name: Orazamide Tablets
English name: Orazamide Tablets
Pinyin: Aolamite Pian
Ingredients This product is the main component of Orazamide,
Chemical name: 4-amino-5-formamide imidazole orotate dihydrate.
Molecular formula: C9H10N6O5 · 2H2O
Molecular weight: 318.26
[Properties] This product is film-coated tablets, remove the coating was white or white.
[Adaptive] for acute and chronic hepatitis, fatty liver and cirrhosis of the adjuvant therapy.
Relieve symptoms of alcoholic hepatitis.
[Specification] 0.1g
Dosage oral, a 2, 3 times a day.
One month a course of treatment.
Generally need 2-3 courses, individual patients need 4 courses was effective.
Serious illness, a dose can be increased to 6-8 tablets.
Adverse reactions are occasional gastrointestinal discomfort and disgusting.
[Taboo] allergy to this product disabled.
[Note] 1, the product traits change, the prohibition of use.
2, please put the child is not easy to get the place.
Pregnant women and lactating women medication pregnant women and lactating women with caution.
Pediatric medication is not clear.
Old age medication is not clear.
Drug interactions are not yet clear.
[Drug overdose] is not clear.
Pharmacology and Toxicology 1, pharmacology: This product in the gastrointestinal fluid is divided into isomeric 4-amino-5-imidazolamide (AICA) and orotic acid (vitamin B13).
AICA is a precursor of purine, and isomeric salts allow AICA to bind to hepatocyte nucleic acids, prevent necrosis of liver parenchymal cells and stimulate the regeneration of hepatocytes.
Does not cause imbalance in the metabolism of nucleic acids, correction of abnormal protein, fat and carbohydrate metabolism.
In the case of acute liver damage to prevent the development of liver fibrosis.
With a strong anti-fatty liver activity, the use of this product for diarrhea patients can increase the patient's urine output, reduce ascites.
It is clinically proven that it enhances the patient's appetite and improves the general symptoms and is particularly effective in improving the serum protein blood, making the jaundice index, aminotransferase, bromophenolphthalein, musk, zinc Turbidity and other indicators of rapid improvement.
This product can improve the digestion and absorption of fat, and contribute to the absorption of vitamin A and K.
2, toxicology: 40 mice, intraperitoneal administration, according to the crown method LD50703.0mg / kg, the average confidence limit: 591-815mg / kg (P = 0.05).
The rabbits, mice, rats were fed with drugs for 6 months without significant differences in teratogenic.
Pharmacokinetics is not yet clear.
[Storage] shading, sealed, stored in a dry place.
[Packing] medicinal PVC hard film, medicinal PTP aluminum foil blister packaging, 10 tablets / plate × 2plates / box.
[Validity] 24 months [Executive Standard] National Drug Administration National Drug Standard WS-10001- (H
D-0384) -2002
[Approval number] GYZZ H43021772
[Manufacturer] Company Name: Hunan Zhongnan Pharmaceutical Co., Ltd.
Production Address: Longxutang, Shaoxing City, Hunan Province, China
Post code: 422001
Phone number: +86-739-5270030 5270119
Fax number: +86-739-5271610
